Halozyme Therapeutics shares owned by EFG Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by EFG Asset Management
from 13F filings
Historical chart of EFG Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by EFG Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by EFG Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $240k | 6.5k | 36.96 |
| 2023-09-30 | $294k | 7.7k | 38.20 |
| 2023-06-30 | $289k | 8.0k | 36.07 |
| 2023-03-31 | $255k | 6.7k | 38.19 |
| 2022-12-31 | $324k | 5.7k | 56.90 |
| 2022-09-30 | $301k | 7.6k | 39.58 |
| 2022-06-30 | $360k | 8.2k | 44.04 |
| 2022-03-31 | $568k | 14k | 39.90 |
| 2021-12-31 | $550k | 14k | 40.19 |
| 2021-09-30 | $446k | 11k | 40.70 |
| 2021-06-30 | $446k | 9.8k | 45.46 |
| 2021-03-31 | $350k | 8.4k | 41.73 |
| 2020-12-31 | $292k | 6.8k | 42.67 |